Welcome!

The primary goal of the Laboratory of Neuropsychopharmacology is to understand the cellular and molecular basis and treatment of complex psychiatric diseases. These include depression, anxiety disorders and schizophrenia with the ultimate goals of development of novel therapeutics and increasing the efficacy of current treatments. To address these issues, we use a variety of molecular, cellular, pharmacological, behavioral and imaging techniques in laboratory animals and humans.

(Front Row) Dr. K.V. Thrivikraman, Dr. Gretchen Neigh, Dr. Becky Kinkead, Dr. Michael J. Owens,
(Second Row) Emily Hardy, Lucy Guillory, Susan Plott
(Third Row) Chase Bourke, Christina Nemeth, Karen Murray, Nicola Hanson
(Back Row) Cory Bradburn, Dr. Jianjun Wang, Faketa Zejnelovic, Hongyan Qu, Catherine Capello